s6y
Company name or ticker
Search
JAY JEFFREY R
4
Adamas Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
Filed
Wednesday, June 21, 2017
Period
Jun 19, 2017
Accession number
0000930413-17-002350
Documents
c88691_4.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header